Approval of Generic Formulation of Lamivudine and Zidovudine Tablets, 150 mg/300 mg - The Body

Links shared publicly online about this topic.

  • 262
    total visits

Approval of Generic Formulation of Lamivudine and Zidovudine Tablets, 150 mg/300 mg - The Body

thebody.com

On May 25, 2011, FDA granted approval for a generic formulation fixed dose combination of lamivudine and zidovudine tablets, 150 mg/300 mg, a two ...

View full resource at thebody.com

Tags: Hepatitis B Medication, HIV, AIDS, HIV Medication, STD, Combivir, Retrovir, Epivir

  • Share

Most Recently Shared on May 27, 2011 at 10:01 pm By:

TheBodyDotCom The Body

Approval of Generic Formulation of Lamivudine and Zidovudine Tablets, 150 mg/300 mg http://bit.ly/jloNoa #hiv #aids #combivir

12 months ago...

Advertisement